fig.7.a

Mimoto MS et al. (2015)

Xla Wt + dndvl2-GFP

NF35/36 (in situ hybridization)

Expression Phenotype
decreased amount tal1.S expression in posterior ventral blood island

fig.S3.a

Mimoto MS et al. (2015)

Xla Wt + gata2 MO

NF15 (real time PCR)

Expression Phenotype
decreased amount tal1.S expression in whole organism

fig.S3.a

Mimoto MS et al. (2015)

Xla Wt + gata2 MO

NF18 (real time PCR)

Expression Phenotype
decreased amount tal1.S expression in whole organism

fig.S4

Mimoto MS et al. (2015)

Xla Wt + LiCl

NF32 (in situ hybridization)

Expression Phenotype
decreased amount tal1.L expression in posterior ventral blood island

Fig. 7 B e-g, l-n; Fig. 7 C o

Buisson I et al. (2015)

Xla Wt + pax8 MO

NF25 (in situ hybridization)

Expression Phenotype
increased amount tal1.L expression in pronephric mesenchyme increased amount aplnr.L expression in pronephric mesenchyme increased amount kdr.L expression in pronephric mesenchyme increased amount lmo2.L expression in pronephric mesenchyme

fig.7.k

Costa RM et al. (2008)

Xla Wt + spib MO

NF22 (in situ hybridization)

Expression Phenotype
increased amount tal1.L expression in anterior ventral blood island

fig.7.l

Costa RM et al. (2008)

Xla Wt + spib MO

NF22 (in situ hybridization)

Expression Phenotype
increased amount tal1.L expression in anterior ventral blood island

Fig. 1 c1r3

Colas A et al. (2008)

Xla Wt + fgf4

NF28 (in situ hybridization)

Expression Phenotype
decreased amount tal1.L expression in dorsal lateral plate mesoderm decreased amount tal1.L expression in ventral blood island